文献速递腹部CTMR

肝细胞癌分期:影像与病理分期的差异及其对肝移植患者选择与结局的意义

Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver Transplantation.
PubMed 文献 · AJR Am J Roentgenol · 2021-08-18

本文综述肝细胞癌影像T分期与移植后病理TNM分期的差异,指出两种分期惯例显著不同,忽略差异是文献中影像-病理分期不一致率高的重要原因,术语不一致也增加混淆,并回顾各分期特征的预后价值,提出可改进术前风险分层的方面以改善移植结局。

要点

  • 影像T分期用于移植候选资格和等待名单优先级,病理TNM分期用于预测移植后结局。
  • 影像与病理分期惯例显著不同,直接比较一致性易高估不一致率。
  • 术语不一致是评估影像-病理分期一致性时混淆的另一来源。

核心结论

  • 影像与病理TNM分期系统惯例显著不同,忽略差异部分导致文献报道的高影像-病理不一致率。
  • 术语不一致增加评估一致性时的混淆,可能影响对重要影像-病理表型及其预后能力的理解。
  • 需认识分期差异以改进术前风险分层,从而积极影响移植后结局。

研究设计与样本

  • 综述类文章,旨在概述肝细胞癌病理与影像TNM分期系统并描述分期流程。
  • 文献回顾聚焦于肝细胞癌分期所用各特征的预后价值。

临床应用与阅片要点

  • 阅片时需明确影像T分期用于移植候选资格与等待名单优先级,而非直接对应病理TNM。
  • 报告时应避免将影像与病理分期术语混用,以减少一致性评估中的混淆。
  • 关注影像特征对术前风险分层的潜在价值,以辅助移植后结局预测。

局限性

  • 为综述性文章,未提供原始研究数据或定量合并分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Liver transplant is indicated with curative intent for patients with early-stage hepatocellular carcinoma (HCC). The radiologic T category is used to determine candidacy and priority of patients on the waiting list. After transplant, the explant liver pathologic TNM stage is used as a predictor of postoperative outcomes and overall prognosis. Although the comparison of radiologic and pathologic T categories for concordance is often considered to be straightforward, the staging conventions significantly differ. Not accounting for these differences is in part the reason for the high rates of radiologic-pathologic discordance reported in the literature, with inconsistent terminology being an additional source of confusion when evaluating concordance. These factors may affect the understanding of important radiopathologic phenotypes of disease and the adequate investigation of their prognostic capabilities. The aims of this article are to provide an overview of the pathologic and radiologic TNM staging systems for HCC while describing staging procedures, emphasize the differences between these staging systems to highlight the limitations of radiologic-pathologic stage correlation, present a review of the literature on the prognostic value of individual features used for HCC staging; and signal significant aspects of preoperative risk stratification that could be improved to positively impact posttransplant outcomes.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Cunha GM, Hosseini M, Furlan A, et al. Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver Transplantation. AJR Am J Roentgenol. 2021. PMID: 34406054. doi:10.2214/AJR.21.26436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。